NECC: Blames Mold at Framingham Pharmacy on Janitors
Wilmington-based UniFirst issued a statement calling the claims “unfounded” and “without merit.”
New England Compounding Center, the Framingham specialty pharmacy company linked to the deadly nationwide meningitis outbreak is blaming its cleaning contractor.
Lawyers for New England Compounding Center (NECC) sent a letter to UniFirst’s “Uniclean” business demanding that it take legal responsibility for the claims made against NECC, first reported the Boston Globe.
“This demand relates to the limited, once-a-month cleaning services the Company provided to portions of NECC’s cleanroom facilities,” an SEC filing by UniFirst stated.
Wilmington-based UniFirst issued a statement calling the claims “without merit.”
“These services were specified by NECC utilizing NECC’s own defined cleansing solutions, and consisted of two UniClean technicians cleaning approximately 1.5 hours each on a monthly basis,” the statement said.” UniClean was not in any way responsible for NECC’s day-to-day operations, its overall facility cleanliness, or the integrity of the products they produced.”
A week before Christmas, New England Compounding Center filed for protection under Chapter 11 of the U.S. Bankruptcy Code.
The Framingham pharmacy has closed, surrendered its license, and recalled its products.
Since it was first identified that patients who received a steroid injection linked to New England Compounding Center in Framingham were contracting fungal meninitis, 39 people have died and more than 650-plus have been infected. (None of the cases are in Massachusetts.)
Let Patch save you time. Get great local stories like this delivered right to your inbox or smartphone everyday with our free newsletter. Simple, fast sign-up here.
Just before Thanksgiving, U.S. District Judge Dennis Saylor has ordered an expedited hearing to determine whether to freeze at least $461 million in assets belonging to New England Compounding Center, its owners and two related companies, as more than 40 lawsuits have been filed in numerous states.
New England Compounding Center (NECC) recalled more than 17,000 steroids in September indicating they may contain a fungus. Later, NECC recalled every product made and laid off all employees.
The FDA released a list of customers, who received products from NECC in Framingham on or after May 21.